HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM (HeatShock)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Agenus, Inc.
Information provided by (Responsible Party):
Andrew Parsa, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00905060
First received: May 18, 2009
Last updated: May 14, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2014
  Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)